Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference Call
October 16 2017 - 4:30PM
Business Wire
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device
company and manufacturer of the only touchscreen insulin pumps
available in the United States, plans to release its third quarter
2017 results after the financial markets close on Thursday, October
26, 2017. The Company will hold a conference call and simultaneous
webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific
Time), to discuss its third quarter 2017 financial and operating
results.
Conference Call/Webcast
Details:Date: October 26, 2017Time: 4:30pm
Eastern Time (1:30pm Pacific Time)Toll Free Dial-In Number:
(855) 427-4396International Dial-In Number: (484)
756-4261Conference ID: 99237651Webcast Link:
https://edge.media-server.com/m6/p/q8bp8b55
An archive of the webcast will be available for 30 days
following the event on Tandem Diabetes Care’s Investor Center
website located at http://investor.tandemdiabetes.com in the
“Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical
device company dedicated to improving the lives of people with
diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach
to the design, development and commercialization of products for
people with diabetes who use insulin. Tandem manufactures and sells
the t:slim X2™ Insulin Pump, the only pump capable of remote
feature updates using a personal computer, now available with
Dexcom G5® Mobile continuous glucose monitoring (CGM) integration,
and the t:flex® Insulin Pump, the first pump designed for people
with greater insulin requirements. Tandem is based in San Diego,
California.
Follow Tandem Diabetes Care on Facebook at
www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at
https://www.linkedin.com/company/tandemdiabetes.
t:flex and Tandem Diabetes Care are registered trademarks, and
t:slim X2 is a trademark of Tandem Diabetes Care, Inc. Dexcom G5 is
a registered trademark of Dexcom, Inc.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171016006119/en/
Tandem Diabetes Care, Inc.Media Contact:Steve Sabicer,
714-907-6264ssabicer@thesabicergroup.comorInvestor
Contact:Susan Morrison, 858-366-6900
x7005smorrison@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Sep 2023 to Sep 2024